Clinical Research Directory
Browse clinical research sites, groups, and studies.
2 clinical studies listed.
Filters:
Tundra lists 2 Retained Placenta clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.
This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.
NCT07875985
Predictors of Successful Office Operative Hysteroscopy Using a Mini-Resectoscope
The goal of this observational study is to identify predictors of successful removal of benign intrauterine pathology using a mini-resectoscope during office operative hysteroscopy without anesthesia in adult women with suspected or diagnosed endometrial polyps or retained products of conception up to 2.5 cm in size. The main questions it aims to answer are: * Which demographic, gynecologic, clinical, and hysteroscopic factors are associated with successful completion of office operative hysteroscopy using a mini-resectoscope without anesthesia? * Which factors are associated with severe pain during the procedure, defined as a Visual Analog Scale (VAS) score greater than 7? * Is prolonged procedure duration (\>3 minutes) associated with higher intraoperative pain scores? * Are there differences in success rates between procedures performed for endometrial polyps versus retained products of conception? Participants will: * Undergo office operative hysteroscopy without anesthesia using the Miniresectoscope device for removal of endometrial polyps or retained products of conception. * Provide demographic, obstetric, gynecologic, and medical history information before the procedure. * Have intraoperative hysteroscopic and surgical characteristics recorded, including cervical stenosis, uterine orientation, lesion size and location, lesion morphology, and procedure duration. * Complete pain assessments using the Visual Analog Scale (VAS) during the procedure and 5 minutes after the procedure. * Be evaluated for procedural success, defined as complete removal of the intrauterine pathology.
Gender: FEMALE
Ages: 18 Years - Any
Updated: 2026-10-15
NCT02969447
Management of Third-stage of Labor After Second Trimester Medical Pregnancy Termination
Prospective randomized trail which compare 2 regimens for third-stage management after second trimester medical pregnancy termination : 10UI intra venous oxytocin or no additional medication after fetal expulsion. Primary outcome was the incidence of placental retention.
Gender: FEMALE
Ages: 18 Years - Any
Updated: 2026-05-12